Health Catalyst Other Stockholder Equity Over Time
| HCAT Stock | USD 8.13 0.00 0.00% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Health Catalyst Performance and Health Catalyst Correlation. Health |
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Health Catalyst. If investors know Health will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Health Catalyst listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.34) | Revenue Per Share 5.123 | Quarterly Revenue Growth 0.035 | Return On Assets (0.05) | Return On Equity (0.21) |
The market value of Health Catalyst is measured differently than its book value, which is the value of Health that is recorded on the company's balance sheet. Investors also form their own opinion of Health Catalyst's value that differs from its market value or its book value, called intrinsic value, which is Health Catalyst's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Health Catalyst's market value can be influenced by many factors that don't directly affect Health Catalyst's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Health Catalyst's value and its price as these two are different measures arrived at by different means. Investors typically determine if Health Catalyst is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Health Catalyst's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Stockholder Equity Analysis
Compare Health Catalyst and related stocks such as National Research Corp, Certara, and Nextgen Healthcare Other Stockholder Equity Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRC | 290 K | 7.6 M | 10.9 M | 13.4 M | 14.8 M | 11.9 M | 13.9 M | 14.1 M | 128.3 M | 128.4 M | 128.1 M | 123.8 M | 97.2 M | 79.5 M | 83.4 M |
| CERT | 507.5 M | 507.5 M | 507.5 M | 507.5 M | 507.5 M | 507.5 M | 507.5 M | 507.5 M | 507.5 M | 509.2 M | 884.5 M | 1.1 B | 1.1 B | 1.2 B | 978.5 M |
| HSTM | 500 K | 154.4 M | 18 K | (31 K) | (37 K) | (70 K) | (51 K) | 25.8 M | 20.8 M | 19.3 M | 19.2 M | 106 K | (981 K) | (1.0) | (0.95) |
| FORA | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 17.5 M | 58 M | 71.2 M | 73.8 M | 48.7 M |
| HQY | 4.8 M | 4.8 M | 4.8 M | 4.8 M | 1.6 M | 199.9 M | 232.1 M | 261.2 M | 305.2 M | 818.8 M | 1.2 B | 1.7 B | 1.7 B | 1.8 B | 1.9 B |
| DH | (131 K) | (131 K) | (131 K) | (131 K) | (131 K) | (131 K) | (131 K) | (131 K) | (131 K) | (131 K) | (131 K) | 889 M | 970.2 M | 1.1 B | 810.1 M |
| EVH | 25.8 M | 25.8 M | 25.8 M | 1.3 M | 27.7 M | (672.2 M) | (639.4 M) | 938.6 M | 1.1 B | 1.2 B | 1.2 B | 1.3 B | 1.5 B | 1.8 B | 1.9 B |
| SLP | 200 K | 5 M | 4.8 M | 6.1 M | 10.2 M | 12 M | 12.9 M | 14.4 M | 15.3 M | 128.5 M | 133.4 M | (308 K) | (1.0) | (1.15) | (1.09) |
| PRVA | 160.4 M | 160.4 M | 160.4 M | 160.4 M | 160.4 M | 160.4 M | 160.4 M | 160.4 M | 160.4 M | 160.4 M | 165.7 M | 633.9 M | 714.6 M | 753.9 M | 534.3 M |
| PINC | 169.1 M | 169.1 M | 182.3 M | 186.6 M | 220.7 M | 265.7 M | 236.5 M | 147.5 M | (87.2 M) | 138.5 M | 2.1 B | 1.9 B | 1.9 B | 1.9 B | 1.9 B |
Health Catalyst and related stocks such as National Research Corp, Certara, and Nextgen Healthcare Other Stockholder Equity description
My Equities
My Current Equities and Potential Positions
| Health Catalyst | HCAT |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Utah; U.S.A |
| Exchange | NASDAQ Exchange |
USD 8.13
Additional Tools for Health Stock Analysis
When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.